When most people get sick with COVID-19 today, they think of it as a brief illness, similar to a cold. However, for a large number of people, the illness doesn't end there. The World Health Organization (WHO) calls this condition long COVID, which is when a person's symptoms continue for at least three months after they first get sick. While much research has focused on the specific symptoms like fatigue and brain fog, a new study from the Australian Journal of Primary Health looks at how these symptoms affect people's daily lives.The study found that long COVID is far more than just a minor annoyance; it can seriously limit a person's ability to do normal daily tasks and participate in their community. The participants reported severe difficulties that could be compared to conditions like stroke, rheumatoid arthritis and Parkinson's disease. So, it is not just more fatigue, but a serious health complication
How Does Long COVID Affect Your Quality Of Life?
The study involved 121 adults in Australia who were dealing with long COVID. Most were between 36 and 50 years old and didn't need to be hospitalized for their initial illness. But months or even years later, they were still struggling with activities that were once easy for them. To get a full picture of the impact, the participants answered two well-known health surveys that measure disability and quality of life. The results were quite powerful.
Does Long COVID Cause Disability?
People with long COVID reported a level of disability that was worse than 98% of the general Australian population. An overwhelming 86% of them met the standards for having a serious disability. On average, they had trouble with daily activities for about 27 days a month and were unable to function for about 18 days. While simple tasks like eating or getting dressed were less affected, more complex activities like doing housework and spending time with friends were severely impacted.
Long COVID and Quality of Life
The condition also had a major negative effect on their overall quality of life, which was 23% lower than the general population's. Their energy levels and social lives were the most affected, showing how fatigue and brain fog can strain relationships and a person's connection to their community.
Should Long COVID Be Taken More Seriously?
The results of this study are similar to what has been found in other countries, showing that long COVID often leads to high levels of disability. The research also highlights how important it is to listen to patients. Since there isn't a single test to diagnose long COVID, a person's own description of their health and recovery was found to be a strong and reliable way to measure their disability and quality of life. This proves that what patients say is not just a "story" but a valid health indicator that captures details medical tests can't.
The study points to an urgent need for better support. A 2023 government inquiry estimated that hundreds of thousands of Australians are living with long COVID. Ignoring this problem could worsen social inequality, as communities that are already struggling are often hit the hardest.
To move forward, we need to create comprehensive support services that go beyond basic medical care. This includes rehabilitation programs to help people manage their fatigue and workplaces that are flexible with hours and job duties. By listening to and respecting the experiences of people with long COVID, the healthcare system can help them regain not only their health but also their dignity and ability to fully participate in life.
News
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
